• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于苯并[de][2,6]萘啶骨架的5-羟色胺5-HT4受体配体的合成及构效关系研究

Synthesis and structure-activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthridine scaffold.

作者信息

Castriconi Federica, Paolino Marco, Giuliani Germano, Anzini Maurizio, Campiani Giuseppe, Mennuni Laura, Sabatini Chiara, Lanza Marco, Caselli Gianfranco, De Rienzo Francesca, Menziani Maria Cristina, Sbraccia Maria, Molinari Paola, Costa Tommaso, Cappelli Andrea

机构信息

Dipartimento di Biotecnologie, Chimica e Farmacia and European Research Centre for Drug Discovery and Development, Università degli Studi di Siena, Via A. Moro 2, 53100 Siena, Italy.

Rottapharm Madaus, Via Valosa di Sopra 9, 20052 Monza, Italy.

出版信息

Eur J Med Chem. 2014 Jul 23;82:36-46. doi: 10.1016/j.ejmech.2014.05.015. Epub 2014 May 5.

DOI:10.1016/j.ejmech.2014.05.015
PMID:24871995
Abstract

A small series of serotonin 5-HT4 receptor ligands has been designed from flexible 2-methoxyquinoline compounds 7a,b by applying the conformational constraint approach. Ligands 7a,b and the corresponding conformationally constrained analogues 8a-g were synthesized and their interactions with the 5-HT4 receptor were examined by measuring both binding affinity and the ability to promote or inhibit receptor-G protein coupling. Ester derivative 7a and conformationally constrained compound 8b were demonstrated to be the most interesting compounds showing a nanomolar 5-HT4R affinity similar to that shown by reference ligands cisapride (1) and RS-23,597-190 (4). The result was rationalized by docking studies in term of high similarity in the binding modalities of flexible 7a and conformationally constrained 8b. The intrinsic efficacy of some selected ligands was determined by evaluating the receptor-G protein coupling and the results obtained demonstrated that the nature and the position of substituents play a critical role in the interaction of these ligands with their receptor.

摘要

通过应用构象限制方法,从柔性2-甲氧基喹啉化合物7a、b设计了一小系列血清素5-HT4受体配体。合成了配体7a、b以及相应的构象受限类似物8a - g,并通过测量结合亲和力以及促进或抑制受体 - G蛋白偶联的能力来研究它们与5-HT4受体的相互作用。酯衍生物7a和构象受限化合物8b被证明是最有趣的化合物,显示出与参比配体西沙必利(1)和RS - 23,597 - 190(4)相似的纳摩尔级5-HT4R亲和力。通过对接研究,根据柔性7a和构象受限8b在结合模式上的高度相似性,对该结果进行了合理说明。通过评估受体 - G蛋白偶联来确定一些选定配体的内在活性,所获得的结果表明取代基的性质和位置在这些配体与其受体的相互作用中起着关键作用。

相似文献

1
Synthesis and structure-activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthridine scaffold.基于苯并[de][2,6]萘啶骨架的5-羟色胺5-HT4受体配体的合成及构效关系研究
Eur J Med Chem. 2014 Jul 23;82:36-46. doi: 10.1016/j.ejmech.2014.05.015. Epub 2014 May 5.
2
Acidic biphenyl derivatives: synthesis and biological activity of a new series of potent 5-HT(4) receptor antagonists.酸性联苯衍生物:新型强效 5-HT(4)受体拮抗剂的合成与生物活性。
Bioorg Med Chem. 2013 Nov 15;21(22):7134-45. doi: 10.1016/j.bmc.2013.09.004. Epub 2013 Sep 11.
3
Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer's disease: the design of donecopride.具有乙酰胆碱酯酶(AChE)抑制和 5-羟色胺能 4 型受体(5-HT4R)激动活性的新型多靶点定向配体(MTDLs)作为潜在的阿尔茨海默病治疗药物:去甲多塞平的设计。
J Med Chem. 2015 Apr 9;58(7):3172-87. doi: 10.1021/acs.jmedchem.5b00115. Epub 2015 Mar 31.
4
New esters of 4-amino-5-chloro-2-methoxybenzoic acid as potent agonists and antagonists for 5-HT4 receptors.4-氨基-5-氯-2-甲氧基苯甲酸的新型酯类作为5-羟色胺4受体的强效激动剂和拮抗剂
J Med Chem. 1997 Feb 14;40(4):608-21. doi: 10.1021/jm960320m.
5
Discovery of TD-8954, a clinical stage 5-HT(4) receptor agonist with gastrointestinal prokinetic properties.发现 TD-8954,一种处于临床研究阶段的 5-HT(4) 受体激动剂,具有胃肠道促动力特性。
Bioorg Med Chem Lett. 2013 Jul 15;23(14):4210-5. doi: 10.1016/j.bmcl.2013.05.018. Epub 2013 May 16.
6
Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease.具有5-羟色胺能4型受体(5-HT4R)部分激动剂和5-HT6R拮抗剂活性的多靶点导向配体的设计、合成及药理学评价,作为阿尔茨海默病的潜在治疗方法。
Eur J Med Chem. 2016 Oct 4;121:283-293. doi: 10.1016/j.ejmech.2016.05.048. Epub 2016 May 26.
7
Dual histamine H3R/serotonin 5-HT4R ligands with antiamnesic properties: pharmacophore-based virtual screening and polypharmacology.具有抗记忆缺失特性的组胺H3R/血清素5-HT4R双重配体:基于药效团的虚拟筛选和多药理学
J Chem Inf Model. 2014 Jun 23;54(6):1773-84. doi: 10.1021/ci500157n. Epub 2014 Jun 10.
8
New benzo[h][1,6]naphthyridine and azepino[3,2-c]quinoline derivatives as selective antagonists of 5-HT4 receptors: binding profile and pharmacological characterization.新型苯并[h][1,6]萘啶和氮杂环庚三烯并[3,2-c]喹啉衍生物作为5-HT4受体的选择性拮抗剂:结合特性和药理学表征
J Med Chem. 2003 Jan 2;46(1):138-47. doi: 10.1021/jm020954v.
9
Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation.发现、口服药代动力学和体内疗效的维鲁司他,一种高度选择性的 5-HT(4)受体激动剂,已在慢性特发性便秘患者中证实了概念验证。
Bioorg Med Chem Lett. 2012 Oct 1;22(19):6048-52. doi: 10.1016/j.bmcl.2012.08.051. Epub 2012 Aug 21.
10
Novel multi target-directed ligands targeting 5-HT receptors with in cellulo antioxidant properties as promising leads in Alzheimer's disease.具有细胞内抗氧化特性的新型多靶点靶向 5-HT 受体的配体作为阿尔茨海默病有希望的先导化合物。
Eur J Med Chem. 2019 Nov 15;182:111596. doi: 10.1016/j.ejmech.2019.111596. Epub 2019 Aug 6.

引用本文的文献

1
Understanding the Molecular Basis of 5-HT Receptor Partial Agonists through 3D-QSAR Studies.通过三维定量构效关系研究理解5-羟色胺受体部分激动剂的分子基础。
Int J Mol Sci. 2021 Mar 30;22(7):3602. doi: 10.3390/ijms22073602.
2
Development of subnanomolar-affinity serotonin 5-HT receptor ligands based on quinoline structures.基于喹啉结构的亚纳摩尔亲和力血清素5-HT受体配体的开发。
Medchemcomm. 2018 Jul 3;9(9):1466-1471. doi: 10.1039/c8md00233a. eCollection 2018 Sep 1.
3
Multivalent ligands for the serotonin 5-HT receptor.用于血清素5-HT受体的多价配体。
Medchemcomm. 2017 Feb 9;8(3):647-651. doi: 10.1039/c6md00458j. eCollection 2017 Mar 1.